US Patent Issued to IncellDx on May 13 for "Methods of assaying neoplastic and neoplasia-related cells and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,298,309, issued on May 13, was assigned to IncellDx Inc. (Hayward, Calif.).

"Methods of assaying neoplastic and neoplasia-related cells and uses thereof" was invented by Bruce K. Patterson (Hayward, Calif.), Amanda Noel Chargin (Hayward, Calif.) and Keith Shults (Hayward, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for assaying neoplastic cells and/or neoplasia-related cells. Aspects of the methods involve detecting heterogeneity, per cell programmed-death ligand 1 (PD-L1) expression, and/or proliferation of neoplasia and/or neoplasia-related cells. Aspects of the methods include cytometrically assaying a labeled cell susp...